Life Healthcare stock trades at EUR 0.67 with a ZAR 12.67 target
Published on 10/15/2026 at 12:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRevenue and analyst valuation
- Life Healthcare reported ZAR 25,398 million in revenue for fiscal year 2025.
- Eulerpool listed a ZAR 12.67 average analyst target in September 2026.
- Life Healthcare stock trades at EUR 0.67 at 12:38 p.m. CEST at Lang & Schwarz on October 15, 2026.
Life Healthcare stock (ISIN ZAE000145892) was at EUR 0.67 at Lang & Schwarz on October 15, 2026, while an average analyst target stood at ZAR 12.67 in September 2026. The target was listed by Eulerpool in its forecast overview.
FY2025 results set baseline
Life Healthcare reported revenue of ZAR 25,398 million for fiscal year 2025, operating income of ZAR 2,528 million and net income of ZAR 3,864 million. Investing.com also listed ZAR 5,025 million in cash from operations for that fiscal year, giving investors a second measure of operating capacity.
The company's investor-relations materials describe two main divisions, Hospitals and Complementary Services, and Healthcare Services. Its activities include acute hospital care, mental healthcare, rehabilitation, occupational health and diagnostic imaging, according to Life Healthcare.
What does valuation imply?
Eulerpool placed the average target at ZAR 12.67 and the median at ZAR 12.55 in September 2026. Its target table showed a maximum of ZAR 13.55 and a minimum of ZAR 12.32, giving the valuation discussion a defined spread rather than a single-point forecast.
A separate Investing.com overview showed an average 12-month target of ZAR 1,301 for the Johannesburg quotation and four analyst ratings in its displayed consensus. The different quotation scales reflect the South African listing data and the euro indication used for German investors.
Euro quote for German investors
Life Healthcare's primary listing is on the Johannesburg Stock Exchange under LHC.JO, with the quoted share price shown in South African cents. The reported fiscal year 2025 figures and the analyst range place the stock in a healthcare valuation discussion centered on earnings capacity, cash generation and target dispersion.
The stock was trading at EUR 0.67 at Lang & Schwarz on October 15, 2026 at 12:38 p.m. CEST. The Johannesburg reference data showed a 52-week range of ZAR 1,000.00 to ZAR 1,302.00, while the euro quotation provides the direct German-market view.
The further course of trading is shown by the continuously updated real-time quote of Life Healthcare stock.
Life Healthcare stock key facts
- Company: Life Healthcare Group Holdings Limited
- ISIN: ZAE000145892
- Ticker: LHC.JO
- Primary exchange: Johannesburg Stock Exchange
- Price Lang & Schwarz (as of October 15, 2026, 12:38 p.m. CEST): EUR 0.67
- Sector / Industry: Healthcare / Medical - Care Facilities
- 52-week range: ZAR 1,000.00-ZAR 1,302.00
Market context: Latest market reports.
